Three Asian recovery stocks with plenty of room to run
Professional investor Ian Hargreaves of the Invesco Asia Trust highlights three of his favourite Asian stocks to buy now.
The V-shaped recovery in Asian equity markets suggests that the region has fared relatively well compared with others. That may ring true given the lower infection rates, fewer deaths and less economic damage incurred by North Asian economies such as Taiwan, Korea and China, but the experience of these countries is not comparable to those of Southeast Asia and India, which have had less success in containing the virus.
We think the best approach is to invest in companies that are worth more than the market believes. We are looking for new stocks trading at significant discounts to our estimate of fair value, with deep discounts currently available in more cyclical areas of the market, where there is less confidence in the pace of recovery.
The companies below interest us because we feel that the pandemic is unlikely to change the long-term fundamentals and there is scope for earnings to recover faster than the market expects as conditions normalise. Furthermore, a degree of balance-sheet strength should offer the business some protection should uncertainty linger.
Subscribe to MoneyWeek
Subscribe to MoneyWeek today and get your first six magazine issues absolutely FREE

Sign up to Money Morning
Don't miss the latest investment and personal finances news, market analysis, plus money-saving tips with our free twice-daily newsletter
Don't miss the latest investment and personal finances news, market analysis, plus money-saving tips with our free twice-daily newsletter
A finger in every pie
Larsen & Toubro (Mumbai: LT) is an Indian conglomerate with a market-leading engineering and construction (E&C) division. The company has diversified over time, with other businesses in IT services, financial services, property development and equity investment in infrastructure projects. We believe the group has a strong management team and is well positioned to gain market share as construction activity improves after several years of underinvestment in India. Our analysis suggests that Larsen’s core E&C business is being valued below the level it reached during the global financial crisis.
Cashing in on cars
Astra International (Jakarta: ASII) has interests in a wide range of market-leading vehicle-related businesses in Indonesia, including four-wheeler manufacturing for Toyota; two-wheeler manufacturing for Honda; car dealerships and vehicle financing. Astra also own a stake in Indonesia’s largest dealer of Komatsu heavy equipment, United Tractors. The shares have derated significantly given uncertain demand due to Covid-19, having been struggling with slower growth in recent years. While the fundamentals of the Indonesian economy are weak in the short term, we believe that demand for vehicles should eventually grow as GDP per capita rises. Astra should also benefit from new Toyota model launches that are expected in 2021.
Yue Yuen Industrial (Hong Kong: 551) is the world’s largest sports shoe manufacturer, serving global brands such as Nike, Adidas and Asics. Lockdowns and store closures saw a sharp decline in sales. By early next year sales should be getting back to normal. The share price, still around 50% below where it was in January, reflects little hope of recovery. The company has relocated manufacturing capacity outside China and invested in automation and a new enterprise resource planning system to enable it to manage shorter lead times from customers better, which should aid its eventual earnings recovery. The shares are on a single digit price/earnings ratio based on our estimate of normalised earnings – a significant discount to fair value.
Sign up for MoneyWeek's newsletters
Get the latest financial news, insights and expert analysis from our award-winning MoneyWeek team, to help you understand what really matters when it comes to your finances.
-
Trump wants to colonise Mars – will it happen?
Donald Trump wants to plant the US flag on Mars. Could humans really live there?
By Simon Wilson
-
Klarna postpones US IPO as Trump's tariffs rattle markets
Buy-now-pay-later lender Klarna has postponed its US initial public offering owing to the market turbulence. It is not alone, says Matthew Partridge
By Dr Matthew Partridge
-
The star small and mid-cap stocks income investors have overlooked
Opinion Thomas Moore, senior investment director, Aberdeen, highlights three company stocks as he shares where he would put his money
By Thomas Moore
-
Falling revenues and mounting debt spell trouble for Jumia Technologies
Struggling African e-commerce platform Jumia Technologies looks headed for the exit, says Dr Matthew Partridge.
By Dr Matthew Partridge
-
Chemring Group: an explosive investment opportunity in defence
European states are raising their military spending, and Chemring Group looks well placed to profit
By Rupert Hargreaves
-
Next reports £1 billion in annual profits for the first time – what's next for the retailer?
Clothing retailer Next has become only the fourth member of its sector to surpass £1 billion in annual profits. What does this mean for the company's future?
By Dr Matthew Partridge
-
Best of British bargains: cash in on undervalued companies in the UK stock market
Opinion Michael Field, Chief Equity Market Strategist, EMEA, Morningstar, selects three attractive UK stocks where he'd put his money
By Michael Field
-
Building firm Keller presents low debt and ample scope for growth
Geotechnical contractor Keller, which supports vital global infrastructure, boasts rising profits and a cheap valuation
By Dr Mike Tubbs
-
PZ Cussons share price down 75% in last decade – why it's one to watch
Opinion Once-strong consumer-goods business PZ Cussons is out of favour with the market. That spells opportunity for investors, says Jamie Ward
By Jamie Ward
-
Cash in on the biotech sector with specialist trust BioPharma
Opinion BioPharma has an attractive niche in lending to asset-rich biotechnology companies
By Rupert Hargreaves